These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7530356)

  • 1. Plasma prothrombotic markers after a short- and middle term treatment with iloprost in arteriopathic patients with critical limb ischemia.
    Ferlito S; Di Salvo MM; Attanasio L; Finocchiaro PM; Condorelli PM; Mazzone D
    Panminerva Med; 1994 Jun; 36(2):76-9. PubMed ID: 7530356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemostatic effects of iloprost in patients with lower limb ischemia.
    Trifiletti A; Scamardi R; Pizzoleo MA; Nevoso A; Soraci S; Bartolone S; Bagnato L; Barbera N
    Panminerva Med; 1997 Sep; 39(3):202-4. PubMed ID: 9360422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemostatic balance in patients with acute focal cerebral vasculopathy.
    Ferlito S; Condorelli M; Mazzone D
    Panminerva Med; 1994 Dec; 36(4):184-7. PubMed ID: 7603735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Iloprost infusion on metabolism in critical limb ischemia, utilizing microdialysis. A pilot study.
    Danielsson P; Metzsch C; Norgren L
    Int Angiol; 2004 Sep; 23(3):259-62. PubMed ID: 15765041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic markers during myocardial infarction.
    Ferlito S; Gallina M; Mangiameli S; Chiaranda G
    Panminerva Med; 1995 Sep; 37(3):133-6. PubMed ID: 8869368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Modification of some prothrombotic indices after treatment with iloprost in arterial disease patients].
    Ferlito S; Bonomo T; Costa R; Di Salvo MM; Attanasio L; Finocchiaro PM; Condorelli M; Mazzone D
    Minerva Cardioangiol; 1996 Dec; 44(12):645-8. PubMed ID: 9053818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is transcutaneous oxygen and carbon dioxide monitoring indispensable in short- and long-term therapeutic management of non-reconstructable lower critical limb ischemia?
    Melillo E; Nuti M; Pedrinelli R; Buttitta F; Balbarini A
    Minerva Cardioangiol; 2006 Aug; 54(4):481-98. PubMed ID: 17016419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Behavior of endothelin plasma levels during iloprost infusion in patients with severe ischemia in the lower extremities].
    Battistelli S; Borgogni T; Gori S; Manasse G
    Minerva Cardioangiol; 1995 Jun; 43(6):257-62. PubMed ID: 7566538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term and long-term effects of one-week treatment with intravenous iloprost in critical limb ischemia patients (Leriche-Fontaine stage III and IV).
    Meini S; De Franco V; Auteri A; Setacci C; Di Renzo M; Pieragalli D
    Int Angiol; 2005 Mar; 24(1):64-9. PubMed ID: 15877001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of iloprost in the treatment of critical ischemia of the limbs].
    Poggesi L; Comeglio M
    Ann Ital Med Int; 1993 Oct; 8 Suppl():71S-77S. PubMed ID: 7509614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outpatient treatment of severe peripheral ischemia with intravenous intermittent low-dose iloprost. An open pilot study.
    Banyai S; Jenelten R; Wagner S; Allmann J; Banyai M; Koppensteiner R
    Int Angiol; 2002 Mar; 21(1):36-43. PubMed ID: 11941272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
    Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and circulatory effects of Iloprost either administered for 1 week or 4 weeks in patients with peripheral obstructive arterial disease at Leriche-Fontaine stage III.
    Arosio E; Sardina M; Prior M; De Marchi S; Zannoni M; Bianchini C
    Eur Rev Med Pharmacol Sci; 1998; 2(2):53-9. PubMed ID: 10229559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative iloprost and endothelial progenitor cells in uremic patients with severe limb ischemia undergoing peripheral revascularization.
    Coppolino G; Buemi A; Bolignano D; Lacquaniti A; La Spada M; Stilo F; De Caridi G; Benedetto F; Loddo S; Buemi M; Spinelli F
    J Surg Res; 2009 Nov; 157(1):e129-35. PubMed ID: 19589539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of coagulation and fibrinolytic systems in patients with CLI is not normalized after surgical revascularisation.
    Pärsson H; Holmberg A; Siegbahn A; Bergqvist D
    Eur J Vasc Endovasc Surg; 2004 Feb; 27(2):186-92. PubMed ID: 14718902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia. The Oral Iloprost in severe Leg Ischaemia Study Group.
    Eur J Vasc Endovasc Surg; 2000 Oct; 20(4):358-62. PubMed ID: 11038148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemostatic status in subjects with deep venous thrombosis].
    Ferlito S; Bonomo T; Pitari G; Puleo R; Condorelli M; Mazzone D
    Minerva Cardioangiol; 1996 Dec; 44(12):649-53. PubMed ID: 9053819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microcirculation and tolerability following i.v. infusion of PGE1 and iloprost: a randomized cross-over study in patients with critical limb ischemia.
    Schellong S; Altmann E; von Bilderling P; Rudofsky G; Waldhausen P; Rogatti W
    Prostaglandins Leukot Essent Fatty Acids; 2004 Jun; 70(6):503-9. PubMed ID: 15120713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between intravenous iloprost and vasoactive drugs in limb ischemia IIB severe. A retrospective analysis.
    Di Salvo MM; Ardita G; Giani L; Mugno F; Stevenazzi F; Mazzone A
    Minerva Cardioangiol; 2006 Jun; 54(3):377-81. PubMed ID: 16733512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tolerance and therapeutic results of iloprost in obliterative arteriopathy in lower limbs at the severe chronic ischemia stage. A retrospective study of 29 consecutive cases].
    Duthois S; Cailleux N; Lévesque H
    J Mal Vasc; 2000 Feb; 25(1):17-26. PubMed ID: 10705132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.